jain.com

Penny Warrant issuance

Company: TeraWulf

This claim was marked delayed on September 14, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2023-09-28
Promised by
2025-12-31
Promised amount
27759265.0 shares
Current status
delayed

The claim, verbatim

Issued warrants to purchase 27,759,265 shares at $0.01 per share, exercisable from April 1, 2024 to December 31, 2025

Source (primary)

TeraWulf S-3 filed 2023-09-29 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “warrants to purchase 27,759,265 shares of Common Stock at an exercise price of $0.01 per share of Common Stock (the "Penny Warrants")...the exercise period for the Penny Warrants is the period beginning on April 1, 2024 and ending at 5:00 p.m., New York City time, on December 31, 2025”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms TeraWulf S-3 filed 2023-09-29

Quote: “warrants to purchase 27,759,265 shares of Common Stock at an exercise price of $0.01 per share of Common Stock (the "Penny Warrants")...the exercise period for the Penny Warrants is the period beginning on April 1, 2024 and ending at 5:00 p.m., New York City time, on December 31, 2025”

View cached copy (2026-09-13)Live source ↗

Record of changes

September 13, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 14, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.